Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapyNils Wilking, Jonas Bergh, Henrik Lindman et al.|Annals of Oncology|2007Cited by 36
Time dependent effects of adjuvant tamoxifen therapy on cerebrovascular disease: results from a randomised trialJohan Rosell, John Carstensen, Bo Nordenskjöld et al.|British Journal of Cancer|2011Cited by 9